Literature DB >> 2050562

The expression of IGF-II in the early post-implantation rat conceptus.

R S Florance1, P V Senior, S Byrne, F Beck.   

Abstract

Insulin-like growth factor II (IGF-II) gene expression was investigated in the early rat conceptus using in situ hybridisation. IGF-II mRNA has been detected as early as 7 days post coitum in the extraembryonic ectoderm of the egg cylinder (including the ectoplacental cone but excluding the trophoblast bordering the implantation chamber). There was no expression either in the early embryo at this stage or in the implanting blastocyst (5.5 days). At 9.5 days transcription was also detected in extra-embryonic mesodermal derivatives and the visceral yolk sac endoderm, but not in the embryonic region. At 10.5 days transcription was detected in embryonic mesodermal derivatives. High levels were found in the primitive heart, hepatic diverticulum and septum transversum; lower levels were found in the early somites and other primitive mesenchymal derivatives and midgut endoderm. No expression was detected at any stage in derivatives of the embryonic ectoderm, including the neurectoderm. Recent studies of IGF-II, the IGF-II/M-6-P receptor and enzymic extracellular matrix remodelling suggest that the expression of IGF-II in the early rat conceptus may be related to hyaluronate breakdown (with, or without, sulphated glycosaminoglycan synthesis), linked with the aggregation and differentiation of previously migrating mesenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050562      PMCID: PMC1224476     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  32 in total

1.  Glycosaminoglycan synthesis in rat embryos during the formation of the primary mesenchyme and neural folds.

Authors:  M Solursh; G M Morriss
Journal:  Dev Biol       Date:  1977-05       Impact factor: 3.582

Review 2.  Binding proteins for the insulin-like growth factors: structure, regulation and function.

Authors:  R C Baxter; J L Martin
Journal:  Prog Growth Factor Res       Date:  1989

Review 3.  Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications.

Authors:  J Zapf; E Rinderknecht; R E Humbel; E R Froesch
Journal:  Metabolism       Date:  1978-12       Impact factor: 8.694

4.  The extracellular matrix of the regenerating newt limb: synthesis and removal of hyaluronate prior to differentiation.

Authors:  B P Toole; J Gross
Journal:  Dev Biol       Date:  1971-05       Impact factor: 3.582

5.  Chemical synthesis and biological studies on mutated gene-control regions.

Authors:  M H Caruthers; S L Beaucage; J W Efcavitch; E F Fisher; R A Goldman; P L deHaseth; W Mandecki; M D Matteucci; M S Rosendahl; Y Stabinsky
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

6.  Isolation and characterization of hyaluronidase from cultures of chick embryo skin- and muscle-derived fibroblasts.

Authors:  R W Orkin; B P Toole
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

7.  Primary structure of human insulin-like growth factor II.

Authors:  E Rinderknecht; R E Humbel
Journal:  FEBS Lett       Date:  1978-05-15       Impact factor: 4.124

Review 8.  Insulin and insulin-like growth factors/somatomedins in fetal and neonatal development.

Authors:  L E Underwood; A J D'Ercole
Journal:  Clin Endocrinol Metab       Date:  1984-03

9.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

Authors:  E Rinderknecht; R E Humbel
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

10.  Chick embryo fibroblasts produce two forms of hyaluronidase.

Authors:  R W Orkin; B P Toole
Journal:  J Cell Biol       Date:  1980-05       Impact factor: 10.539

View more
  1 in total

1.  Growth promoting effects of human placental lactogen during early organogenesis: a link to insulin-like growth factors.

Authors:  A K Karabulut; R Layfield; M K Pratten
Journal:  J Anat       Date:  2001-06       Impact factor: 2.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.